Jean Coutu Group (PJC) (A) (PJC.A.TO) Buy,…

Jean Coutu Group (PJC) (A) (PJC.A.TO)

0.00

-0.00 (0.00%)

22 watching

BUY

Should improve making its absorption of Eckerds. Highly skilled company with a good history in the north eastern part of the US. It will gradually come through looking very good.

Wealthica Track your Stocks in your Watch List

BUY

Their business has been primarily in Quebec and North Eastern US and their acquisition of Eckerd's, although risky, should pay off. This quarter is the first one where they show the results of Eckerd's and there will be a lot of transition costs. Very good management. May have to be patient. Good sector.

BUY

Has really bitten off a big chunk with its Eckards acquisition in the US. Have delayed their numbers because the accounting issues are so complex. This makes him nervous.

PAST TOP PICK

(A Top Pick Oct 27/04. Up 4%.) Owns this one for a long term hold. Will take 1/2 years before they start to see the payoff in their US acquisition.

TOP PICK

Not for short term, hot money investors. A BUY and HOLD stock. Their history of buying and turning around US companies is good, so Ekard acquisition will start showing results in about a year.

DON'T BUY

Shoppers is much less risk. If they get their Ekard Drugs working, then they will do well, but in the meantime, would stick with Shoppers.

BUY

The big question is will they be able to turn around the half of the Ekard assets. Have had experience in other US assets and they like.

PAST TOP PICK

(A Top Pick July 27/04. Down 11%.) Still likes. Will probably take a year to integrate the Ekard chain. It's not a case of "if" they'll be successful, but "when".

Wealthica Track your Stocks in your Watch List

TOP PICK

Doesn't care what it does in the next year. It will take a year or two to get Eckard to look they way they want it. That's when the big payoff will come.

BUY ON WEAKNESS

Has made a lot of astute acquisitions. Good solid company and great management. May be over extended with their Eckard acquisition. Would buy 25/30% lower.

TOP PICK

Strongly believe that it was a great move on their part making the US acquisition.

BUY

A defensive growth stock. Will continue to do well even in a recession.

WAIT

Have the wherewithal to address the issues that are imperative to benefit from the large transaction recently made. It'll be a tough haul for them.

TOP PICK

This is a drug store chain. This is a relatively low risk stock. They have been in U.S. and they know the U.S. market.

BUY

There is an uptrend line from early 2003 which intersects at roughly $16.70. One worry is that it didn't get past its old high of $20 this year. Good price.

Showing 136 to 150 of 204 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Jean Coutu Group (PJC) (A) (PJC.A.TO)